Pancreatic Cancer Research

ResearcherWest Cancer CenterNo recent work listed

Lee Steven Schwartzberg

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7433-3428; OpenAlex author ID A5072563567. Sources: ClinicalTrials.gov.

Their work

Papers
2 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pan… Co-author DOI 10.7150/jca.15407↗
  2. The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting. Last author DOI 10.1097/mpa.0b013e318254f19a↗

Trials 1

  1. Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Principal investigator NCT00733850↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dapeng Li · 1 shared paper, 2017 · strength 0.07
  2. Edward J. Stepanski · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.